Across TCGA patient cohorts, BTBD10P2 RNA expression is significantly associated with the RNA expression of many other genes, with 16,219 significant associations in total. UVM shows the largest number of these associations.

The most reproducible BTBD10P2-associated genes across cancer lineages are LATS1, CHP1P2, and MED23. Each is linked with BTBD10P2 in more than 29 cancer types. Because this analysis shows association rather than direction, both BTBD10P2-to-partner and partner-to-BTBD10P2 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (BTBD10P2→partner) and Y-score (partner→BTBD10P2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
CHOL	LATS1 →	+1.108	+0.373	<.001	.001	3	30
LAML	CHP1P2 →	+1.217	+0.728	<.001	<.001	3	30
UVM	MED23 →	+1.043	+0.190	<.001	<.001	3	29
DLBC	CASP8AP2 →	+1.086	+0.245	<.001	<.001	3	29
DLBC	SHPRH →	+0.743	+0.276	<.001	<.001	3	29
UVM	ZNF449 →	+0.967	+0.194	<.001	<.001	3	29

Each partner links to its Q-omics profile. Showing the 6 strongest of 16,219 associations by consensus.

Exploration

BTBD10P2 survival (RNA) · tumor vs normal (RNA) · all BTBD10P2 data types